Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Triquetra Health Launches Saffron Kids™--First USDA Organic Sargol-Grade Saffron Extract Studied in Children at the Label Dose

Triquetra Health is a health supplement brand designed with nature and science.

News provided by

Triquetra Health LLC

Sep 03, 2026, 08:00 ET

Share this article

Share toX

Share this article

Share toX

Saffr'Activ® Liquid Drops Support Focus, Mood, Calm Behavior, and Restful Sleep for Ages 3 Through 17

AUSTIN, Texas, Sept. 3, 2026 /PRNewswire/ -- Triquetra Health, an evidence-based supplement company specializing in clinically-studied formulations, today announced the launch of Saffron Kids™, a USDA Organic Sargol-grade saffron extract built around Saffr'Activ®—the saffron extract studied in kids at the dose in this bottle. The pediatric liquid supplement is now available on Amazon, supporting focus, mood, calm behavior, and restful sleep for children and teens ages 3 through 17 in an alcohol-free, sugar-free berry-flavored format.

Continue Reading
Support growing minds with SaffronRX® Kids Formula 🌿✨

Made with clinically studied saffron extract in a natural berry flavor, this kids formula is designed to support focus, mood, and restful sleep as little ones grow and develop.
Support growing minds with SaffronRX® Kids Formula 🌿✨ Made with clinically studied saffron extract in a natural berry flavor, this kids formula is designed to support focus, mood, and restful sleep as little ones grow and develop.

Most kids supplements aren't studied in kids. The research behind conventional pediatric formulations, when it exists at all, is typically extrapolated from adult studies or animal data—leaving parents to rely on marketing claims rather than dose-matched evidence. With pediatric supplement use rising and parents increasingly seeking clean, research-backed wellness options for their children, the category has lacked products combining published pediatric clinical evidence with the certifications and format quality parents expect for the rest of their family's purchases.

Saffron Kids™ addresses this gap through Saffr'Activ®—USDA Organic Sargol-grade saffron extract from Iran's Khorasan region, preserved by patented DryCare® low-temperature drying that protects heat-sensitive crocins from degradation. The formulation delivers 30 mg per daily serving for ages 7 through 17—matching the exact daily amount used in the published pediatric clinical trial—with a body-weight-scaled 15 mg dose for ages 3 through 6. The calibrated dropper covers ages 3 through 17 from one bottle. Unlike conventional multi-ingredient pediatric blends where each component is mathematically diluted below clinically studied levels, Saffron Kids™ uses a single, mechanistically coherent ingredient at the studied dose.

The product is available at amazon.com/dp/[ASIN - B0H9BPL7JF]

A clinical trial published in the peer-reviewed journal Nutrients in 2022 evaluated Saffr'Activ® in 63 children and teens ages 7 through 17 over three months at the 30 mg daily dose now delivered in Saffron Kids™. The published research examined attention, executive function, behavior, and sleep onset across the three-month protocol. Published. Peer-reviewed. In children. The Saffr'Activ® extract in Saffron Kids™ is the same branded ingredient at the same daily dose used in the published study—what Triquetra Health describes as the standard parents should be asking for in the pediatric supplement category.

"Most kids supplements aren't studied in kids—the research, when it exists at all, was usually done in adults and scaled down with hope rather than evidence," said Sean Gill, Founder and CEO of Triquetra Health.
 "We built Saffron Kids™ around Saffr'Activ® specifically because it's the saffron extract studied in a published pediatric clinical trial at exactly the daily dose we put in this bottle. Focus. Mood. Calm. Sleep.—from one ingredient parents can defend to their pediatrician and feel good about giving every day."

Saffron Kids™ features 30 mg of Saffr'Activ® USDA Organic Sargol-grade saffron extract per serving, standardized to greater than 3% crocins by HPLC and greater than 2% safranal by UV—the two bioactives behind the published pediatric research. The 1 fl oz amber dropper bottle delivers approximately 60 servings for ages 3 through 6 and 30 servings for ages 7 through 17—ages 3 through 17 from one bottle. The formula is manufactured in a cGMP-certified facility, certified organic by Oregon Tilth, non-GMO, vegan, and allergen-free (no soy, gluten, dairy, peanut, tree nut, fish, shellfish, or sesame). For complete product information, visit triquetrahealth.com/products/saffron-kids.

Saffron Kids™ is available now on Amazon at https://www.amazon.com/dp/ [ASIN - B0H9BPL7JF] with a 60-day satisfaction guarantee. For published pediatric research details and complete formulation information, visit triquetrahealth.com/products/saffron-kids.

About Triquetra Health

Triquetra Health develops research-backed supplements for cognitive wellness and neurological support. The company focuses on formulation science and rigorously sourced branded ingredients that match published clinical research at the label dose. All products are manufactured in FDA-registered, cGMP-certified facilities with comprehensive third-party verification. For more information, visit triquetrahealth.com.

Media Contact
LeAnna Doughty
Director of Communications
[email protected]
+ (844) 272-6337

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

SOURCE Triquetra Health LLC

21%

more press release views with 
Request a Demo

Modal title

Also from this source

Triquetra Health Launches BioActive Vitamin B1™--First Complete Activation System with 5-11× More Usable B1 Plus the Cofactors That Unlock It

Triquetra Health Launches BioActive Vitamin B1™--First Complete Activation System with 5-11× More Usable B1 Plus the Cofactors That Unlock It

Triquetra Health, a clinical-grade supplement company specializing in evidence-based formulation, today announced the launch of BioActive Vitamin...

Triquetra Health Launches BioActive Vitamin B1™--First Complete B1 Activation System with 600mg Research-Matched Dose and Full Cofactor Support

Triquetra Health Launches BioActive Vitamin B1™--First Complete B1 Activation System with 600mg Research-Matched Dose and Full Cofactor Support

Triquetra Health, a clinical-grade supplement company specializing in evidence-based formulation, today announced the launch of BioActive Vitamin B1™ ...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Fitness/Wellness

Fitness/Wellness

Mental Health

Mental Health

Supplementary Medicine

Supplementary Medicine

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content

About

  • About PR Newswire
  • About Cision
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2026 Cision US Inc.